FdaApplication

ANDA 217875

Back to search

Identifiers

Properties

PropertyValue
applicant_nameALKEM LABORATORIES LTD
application_typeANDA
approval_date2023-08-24

Products (4)

ProductActive ingredientStrengthDosage form
TEMAZEPAMTEMAZEPAM22.5MGCAPSULE;ORAL
TEMAZEPAMTEMAZEPAM30MGCAPSULE;ORAL
TEMAZEPAMTEMAZEPAM15MGCAPSULE;ORAL
TEMAZEPAMTEMAZEPAM7.5MGCAPSULE;ORAL

4 products